The Eyes Have It

From Yahoo/Reuters:

Health officials on Friday announced plans aimed at reducing the time and cost of bringing new drugs, vaccines and medical devices to the U.S. market.

Concerned by a drop in the number of applications filed and new drugs approved in recent years, the Food and Drug Administration (news – web sites) said it will strive to avoid sending products through multiple review cycles, a major cause of delays.

From Newsday:

Worried about a serious slowdown in the creation of novel drugs, the government is taking steps it hopes will speed medical innovation, largely by making clearer how companies can prove a new product works before they waste time researching the wrong thing.